跳至主要内容
临床试验/NCT04077268
NCT04077268已完成不适用

Becoming Traumatic Brain Injured Patients at Day 7 of Their Trauma in Poitiers Emergency

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2019年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Becoming of traumatic brain injured patients: becoming classified in alive with or without sequelae or death, by using scale of GOS E

研究概览

简要总结

To study the future of traumatic brain injured patients at day 7 of their trauma

Primary endpoint: Fate, classified as survival with or without sequelae, death. Use of the GOS-E scale to classify survival with or without sequelae. The collection of this scale will be done by telephone contact, 7 days of admission to the emergency room.

Secondary judgment criteria:

  • Compendium of the realization of the CT / time respected between the TCL and the CT / Hospitalization / 2nd CT to realize at 24 hours in the patients treated by TAC or AAP
  • Application of the recommendations of the French Society of Emergency Medicine 2012: Become 7 days of patients classified according to whether or not the recommendations, .
  • Become TCL patients under AAP or TAC
  • Number of reconsultation, rehospitalization, new imaging within 7 days after TCL

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient of both sexes, at least 18 years old,
  • Patient with mild head trauma, Glasgow 13-15
  • Patient without tutorship or curatorship
  • Affiliation to social security
  • No opposition of the patient or relatives to participation in the study.

排除标准

  • Patient already included in this study
  • Refusal to participate in this search
  • Patient undergoing enhanced protection (persons deprived of liberty by a judicial or administrative decision, adults under legal protection).

结局指标

主要结局

Becoming of traumatic brain injured patients: becoming classified in alive with or without sequelae or death, by using scale of GOS E

时间窗: 7 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验